<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="other" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">TDO</journal-id>
<journal-id journal-id-type="hwp">sptdo</journal-id>
<journal-title>Tropical Doctor</journal-title>
<issn pub-type="ppub">0049-4755</issn>
<issn pub-type="epub">1758-1133</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0049475513483726</article-id>
<article-id pub-id-type="publisher-id">10.1177_0049475513483726</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Correspondence</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>To Buruli or not to Buruli</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name><surname>Ho</surname><given-names>Leo</given-names></name>
<xref ref-type="aff" rid="aff1-0049475513483726">1</xref>
<xref ref-type="corresp" rid="corresp1-0049475513483726"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Cohn</surname><given-names>Jennifer</given-names></name>
<xref ref-type="aff" rid="aff2-0049475513483726">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Comte</surname><given-names>Eric</given-names></name>
<xref ref-type="aff" rid="aff3-0049475513483726">3</xref>
</contrib>
</contrib-group>
<aff id="aff1-0049475513483726"><label>1</label>Pediatric Advisor, Médecins Sans Frontières Operational Center, Switzerland</aff>
<aff id="aff2-0049475513483726"><label>2</label>Medical Coordinator, MSF Access Campaign, Switzerland</aff>
<aff id="aff3-0049475513483726"><label>3</label>Medical Director, Médecins Sans Frontières Operational Center, Switzerland</aff>
<author-notes>
<corresp id="corresp1-0049475513483726">Leo Ho, Médecins Sans Frontières Operational Center, Rue de Lausanne 78, Geneva 1211, Switzerland. Email: <email>leo.ho@geneva.msf.org</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>4</month>
<year>2013</year>
</pub-date>
<volume>43</volume>
<issue>2</issue>
<fpage>92</fpage>
<lpage>92</lpage>
<permissions>
<copyright-statement>© The Author(s)  2013 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2013</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
</article-meta>
</front>
<body>
<p>Kiiza and Wood (January 2012, p. 48)<sup><xref ref-type="bibr" rid="bibr1-0049475513483726">1</xref></sup> describe a case report of an 18-day-old infant with a purulent necrotizing cutaneous lesion of the anterior thorax which they subsequently clinically diagnose as <italic>Mycobacterium ulcerans</italic> (Buruli ulcer). Although the infant’s necrotizing lesion was surgically drained via a manual probe on three occasions, confirmatory laboratory testing for <italic>M. ulcerans</italic> was not done. To our knowledge, no laboratory-confirmed case of <italic>M. ulcerans</italic> in the neonatal period has been described in the medical literature. <italic>M. ulcerans</italic> transmission is hypothesized to occur via bites of aquatic insects, to which the child was not likely to have been exposed, and there has been no published evidence for human-to-human transmission.<sup><xref ref-type="bibr" rid="bibr2-0049475513483726">2</xref></sup> As <italic>M. ulcerans</italic> is a slow-growing mycobacteria, even in an infant with an under-developed immune system, the incubation time of 14 days is extremely short. For these reasons, we would like to call the diagnosis of <italic>M. ulcerans</italic> into question.</p>
<p>Bacterial abscess and necrotizing fasciitis should be included in the differential diagnosis of a rapidly progressive necrotizing cutaneous infection in a neonate. Bacterial abscesses are most commonly caused by Gram positive bacteria such as <italic>Staphylococcus aureus</italic> and Group A streptococcus (<italic>S. pyogenes</italic>) while neonatal necrotizing fasciitis is often a polymicrobial infection (Gram positive, Gram negative and anaerobic bacteria). Despite the polymicrobial nature of neonatal necrotizing fasciitis, the most commonly isolated bacterium is <italic>S. aureus</italic>.<sup><xref ref-type="bibr" rid="bibr3-0049475513483726">3</xref></sup></p>
<p>The mother of the affected infant had breast fissures on admission which subsequently developed into abscesses requiring incision and drainage. Both mother and infant were treated with rifampin monotherapy on the assumption that the infection was caused by <italic>M. ulcerans</italic> and, since both improved, the treatment was considered to have been successful. However, breast abscesses are most commonly caused by <italic>S. aureus</italic>.<sup><xref ref-type="bibr" rid="bibr4-0049475513483726">4</xref></sup> As the infant could have easily become colonized with <italic>S. aureus</italic> from the mother’s superinfected breast fissures, there is reasonable likelihood that both infant and mother had cutaneous <italic>S. aureus</italic> infection rather than an infection caused by <italic>M. ulcerans</italic>. Improvement in both mother and child after being treated with rifampin monotherapy could be explained by rifampin’s significant in vitro activity against <italic>S. aureus</italic> rather than <italic>M. ulcerans</italic>.<sup><xref ref-type="bibr" rid="bibr5-0049475513483726">5</xref></sup> In addition, both mother and child could have improved as a result of both undergoing incision and drainage of their abscesses which is the standard of care in the treatment of bacterial abscesses.</p>
<p>Rifampin monotherapy is not recommended for the treatment of <italic>M. ulcerans</italic>. The World Health Organization<sup><xref ref-type="bibr" rid="bibr6-0049475513483726">6</xref></sup> recommends first line treatment of <italic>M. ulcerans</italic> with rifampin and intramuscular streptomycin. For pregnant and/or lactating women, streptomycin may be replaced by clarithromycin in order to avoid potential toxicity.</p>
</body>
<back>
<ref-list>
<title>References</title>
<ref id="bibr1-0049475513483726"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kiiza</surname><given-names>AM</given-names></name><name><surname>Wood</surname><given-names>PB</given-names></name></person-group>. <article-title>Buruli ulcer in an 18-day-old baby</article-title>. <source>Trop Doct</source> <year>2012</year>; <volume>42</volume>: <fpage>48</fpage>–<lpage>48</lpage>.</citation></ref>
<ref id="bibr2-0049475513483726"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Röltgen</surname><given-names>K</given-names></name><name><surname>Qi</surname><given-names>W</given-names></name><name><surname>Ruf</surname><given-names>MT</given-names></name><etal/></person-group>. <article-title>Single nucleotide polymorphism typing of mycobacterium ulcerans reveals focal transmission of Buruli ulcer in a highly endemic region of Ghana</article-title>. <source>PLoS Negl Trop Dis</source> <year>2010</year>; <volume>4</volume>: <fpage>e751</fpage>–<lpage>e751</lpage>.</citation></ref>
<ref id="bibr3-0049475513483726"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hsieh</surname><given-names>WS</given-names></name><name><surname>Yang</surname><given-names>PH</given-names></name><name><surname>Chao</surname><given-names>HC</given-names></name><name><surname>Lai</surname><given-names>JY</given-names></name></person-group>. <article-title>Neonatal necrotizing fasciitis: A report of three cases and review of the literature</article-title>. <source>Pediatrics</source> <year>1999</year>; <volume>103</volume>: <fpage>e53</fpage>–<lpage>e53</lpage>.</citation></ref>
<ref id="bibr4-0049475513483726"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bharat</surname><given-names>A</given-names></name><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Aft</surname><given-names>RL</given-names></name><etal/></person-group>. <article-title>Predictors of primary breast abscess and recurrence</article-title>. <source>World J Surg</source> <year>2009</year>; <volume>33</volume>: <fpage>2582</fpage>–<lpage>2582</lpage>.</citation></ref>
<ref id="bibr5-0049475513483726"><label>5</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>DN</given-names></name><name><surname>Moellering</surname><given-names>RC</given-names><suffix>Jr</suffix></name><name><surname>Eliopoulos</surname><given-names>GM</given-names></name><etal/></person-group>. <source>Sanford Guide to Antimicrobial Therapy</source>, <publisher-loc>Virginia</publisher-loc>: <publisher-name>Stanford Guide</publisher-name>, <year>2010</year>.</citation></ref>
<ref id="bibr6-0049475513483726"><label>6</label><citation citation-type="book"><collab>World Health Organization</collab>. <source>Treatment of <italic>Mycobacterium ulcerans</italic> disease (Buruli ulcer): guidance for health workers</source>, <publisher-loc>Geneva</publisher-loc>: <publisher-name>WHO</publisher-name>, <year>2012 (in press)</year>.</citation></ref>
</ref-list>
</back>
</article>